An evaluation of the basal expression of IGF-IR and ErbB family receptors and signaling pathway proteins showed no correlation between the levels of these receptors and sensitivity to their inhibition, in good agreement with previous results in several types of cancer [38,41,42]. This evidence concerns the gene EGFR and cancer.